Bladder Cancer - Results from #160

Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity. February 14, 2020

Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and Bioinformatics. February 14, 2020

Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. February 14, 2020

Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions. February 14, 2020

The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. February 14, 2020

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer. February 13, 2020

Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial. February 13, 2020

Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study. February 13, 2020

Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. February 12, 2020

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis. February 12, 2020

Massive Neobladder Stones in Post-Cystectomy Patient Lost to Follow Up. February 12, 2020

Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer. February 11, 2020

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. February 11, 2020

First experience with a new form of orthotopic ileal neobladder (Leuven N-Pouch) following radical cystectomy. February 11, 2020

Disease Progression Among Patients Who Receive Available Bladder Preservation Therapies After Failure of Bacillus Calmette-Guérin (BCG) Therapy in the SEER-Medicare Data February 10, 2020

Safety and Efficacy of Intravesical Nadofaragene Firadenovec for Patients with High-Grade, Bacillus Calmette-Guérin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) February 10, 2020

Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives. February 10, 2020

Neoadjuvant vs adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis. February 10, 2020

Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion? February 10, 2020

Atypical Early Recurrence after Robot-Assisted Radical Cystectomy: Port-Site Metastasis. February 7, 2020

Page 9 of 336